Lipocine (LPCN) Liabilities and Shareholders Equity (2011 - 2025)
Lipocine's Liabilities and Shareholders Equity came in at $17.01 million for Q4 2025, down 24.5% from $22.51 million a year earlier but up 5.8% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Liabilities and Shareholders Equity (2011 - 2025) Analysis & Trends
Going back to Q4 2011, Lipocine's Liabilities and Shareholders Equity data covers 56 quarters.
- Liabilities and Shareholders Equity has declined in each of the last four years, with a five-year compound annual growth rate of -7.7% (FY2020 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $22.51 million in FY2024 (-2.1%), $23 million in FY2023 (-38.7%), $37.54 million in FY2022 (-28.5%) and $52.48 million in FY2021 (+107.0%).
- The five-year range for quarterly Liabilities and Shareholders Equity is $16.07 million (Q3 2025) to $52.48 million (Q4 2021).
- Year-over-year, Liabilities and Shareholders Equity has declined for 16 consecutive quarters, with an average decline of 19.2% over the last eight quarters.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q1 2021 (growth of 140.9%), and the weakest in Q4 2023 (a decline of 38.7%).
- Business Quant data shows LPCN's Liabilities and Shareholders Equity at $16.07 million (Q3 2025), $18.58 million (Q2 2025) and $20.5 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Lipocine | 11.92 Mn | -55.79 Mn | - | 17.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 17.01 Mn |
| Sep 30, 2025 | 16.07 Mn |
| Jun 30, 2025 | 18.58 Mn |
| Mar 31, 2025 | 20.50 Mn |
| Dec 31, 2024 | 22.51 Mn |
| Sep 30, 2024 | 20.70 Mn |
| Jun 30, 2024 | 23.03 Mn |
| Mar 31, 2024 | 25.45 Mn |
| Dec 31, 2023 | 23.00 Mn |
| Sep 30, 2023 | 24.75 Mn |
| Jun 30, 2023 | 30.48 Mn |
| Mar 31, 2023 | 34.02 Mn |
| Dec 31, 2022 | 37.54 Mn |
| Sep 30, 2022 | 39.42 Mn |
| Jun 30, 2022 | 42.19 Mn |
| Mar 31, 2022 | 47.60 Mn |
| Dec 31, 2021 | 52.48 Mn |
| Sep 30, 2021 | 40.39 Mn |
| Jun 30, 2021 | 47.18 Mn |
| Mar 31, 2021 | 50.58 Mn |
API Access
Lipocine Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();